Over the last 50 years the prognosis for growth and pubertal development in children with type 1 diabetes mellitus (T1DM) has improved considerably. The early reports of Mauriac’s syndrome were related not only to relative deficiency of insulin but also reduced caloric intake. Improved insulin delivery and liberalisation of caloric intake has resulted in improved growth, but subtle abnormalities persist. The frequently reported increased height at diagnosis may relate to prior hyperinsulinaemia and genetic background with respect to lDDM2 the insulin gene VNTR. Subsequent growth faltering is thought to be related to impairment of the GH/IGF-1 axis but children with T1DM are also more at risk of hypothyroidism and coeliac disease. At puberty, persisting abnormalities of the GH/IGF-1 axis and our inability to reverse these totally, even with intensified insulin therapy, contribute to the blunted pubertal growth in the girls but abnormal sex steroid concentrations may also be important. Intensification of insulin therapy may result in leptin resistance and excessive gains in fat mass, particularly in girls. Although it is likely that most children with T1DM will have normal final heights, this excessive weight gain in girls may lead to problems with compliance. Furthermore, hyperinsulinaemia in these subjects may also lead to ovarian hyperandrogenism, increased early risk of microvascular complications and long-term risk of cardiovascular disease.

Songer TJ, LaPorte RE, Tajima N, Orchard TJ, Rabin BS, Eberhardt MS, Dorman JS, Cruickshanks KJ, Cavender DE, Becker DJ, et al: Height at diagnosis of insulin-dependent diabetes in patients and their non-diabetic family members. Br Med J (Clin Res Ed) 1986;292:1419–1422.
Edelsten AD, Hughes IA, Oakes S, Gordon IR, Savage DC: Height and skeletal maturity in children with newly-diagnosed juvenile-onset diabetes. Arch Dis Child 1981;56:40–44.
Drayer NM: Height of diabetic children at onset of symptoms. Arch Dis Child 1974;49:616–620.
Jivani SK, Rayner PH: Does control influence the growth of diabetic children? Arch Dis Child 1973;48:109–115.
Salardi S, Tonioli S, Tassoni P, Tellarini M, Mazzanti L, Cacciari E: Growth and growth factors in diabetes mellitus. Arch Dis Child 1987;62:57–62.
Price DE, Burden AC: Growth of children before onset of diabetes. Diabetes Care 1992;15:1393–1395.
Evans N, Robinson VP, Lister J: Growth and bone age of juvenile diabetics. Arch Dis Child 1972;47:589–593.
Emmerson AJ, Savage DC: Height at diagnosis in diabetes. Eur J Pediatr 1988;147:319–320.
Hoskins PJ, Leslie RD, Pyke DA: Height at diagnosis of diabetes in children: A study in identical twins. Br Med J (Clin Res Ed) 1985;290:278–280.
Lee TJ, et al: Growth in children with diabetes; in Borms J (ed): Human Growth and Development. New York, Plenum Press, 1984, pp 613–618.
Brown M, Ahmed ML, Clayton KL, Dunger DB: Growth during childhood and final height in type 1 diabetes. Diabet Med 1994;11:182–187.
Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. I. Arch Dis Child 1996;41:454–471.
Anonymous: Height at onset of insulin-dependent diabetes mellitus in high- and low-risk countries. Japan and Pittsburgh Childhood Diabetes Research Groups. Diabetes Res Clin Pract 1989;6:173–176.
Ramachandran A, Snehalatha C, Joseph TA, Vijay V, Viswanathan M: Height at onset of insulin-dependent diabetes in children in southern India. Diabetes Res Clin Pract 1994;23:55–57.
Leslie RD, Lo S, Millward BA, Honour J, Pyke DA: Decreased growth velocity before IDDM onset. Diabetes 1991;40:211–216.
Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK: Obesity, increased linear growth and risk of type 1 diabetes in children. Diabetes Care, 2000;23:1755–1760.
Baum JD, Ounsted M, Smith MA: Weight gain in infancy and subsequent development of diabetes mellitus in childhood (letter). Lancet 1975;ii:866.
Hypponen E, Kenward MG, Virtanen SM, Piitulainen A, Virta-Autio P, Tuomilehto J, Knip M, Akerblom HK: Infant feeding, early weight gain and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999;22:1961–1965.
Johansson C, Samuelsson U, Ludvigsson J: A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994;37:91–94.
Domargard A, Sarnblad S, Kroon M, Karlsson I, Skeppner G, Aman J: Increased prevalence of overweight in adolescent girls with type 1 diabetes mellitus. Acta Paediatr 1999;88:1223–1228.
Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997;15:289–292.
Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA: IDDM2-VNTR-encoded susceptibility to type 1 diabetes: Dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996;9:415–421.
Le-Stunff C, Fallin D, Schork NJ, Bougneres P: The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nat Genet 2000;26:444–446.
Ong KK, et al: Genetic influences on fetal growth; in O’Brien PMS (ed): Fetal Programming: Influences on Development and Disease in Later Life. London, RCOG Press, 1999, pp 85–96.
Brismar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab 1994;79:872–878.
Dunger DB: Insulin and insulin-like growth factors in diabetes mellitus. Arch Dis Child 1995;72:469–471.
Du Caju MV, Rooman RP, Op de Beeck L: Longitudinal data on growth and final height in diabetic children. Pediatr Res 1995;38:607–611.
Tillmann V, Adojaan B, Shor R, Price DA, Tuvemo T: Physical development in Estonian children with type 1 diabetes. Diabet Med 1996;13:97–101.
Ahmed ML, Connors MH, Drayer NM, Jones JS, Dunger DB: Pubertal growth in IDDM is determined by HbA1c levels, sex and bone age. Diabetes Care 1998;21:831–835.
Clayton KL, Holly JM, Carlsson LM, Jones J, Cheetham TD, Taylor AM, Dunger DB: Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-1 in adolescents with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 1994;41:517–524.
Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI: Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 1987;330:537–543.
Mortensen HB, Hartling SG, Petersen KE: A nation-wide cross-sectional study of glycosylated haemoglobin in Danish children with type 1 diabetes. Diabet Med 1988;5:871–876.
Anonymous: Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care 1988;11:567–573.
Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP: Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990;71:1356–1362.
Rudberg S, Persson B: Indications of low sex hormone binding globulin in young females with type 1 diabetes, and an independent association to microalbuminuria. Diabet Med 1995;12:816–822.
Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W: Serum androgen levels in adolescents with type 1 diabetes: Relationship to pubertal stage and metabolic control. J Endocrinol Invest 2000;23:362–368.
Djursing H, Hagen C, Nyboe-Andersen A, Svenstrup B, Bennett P, Molsted-Pedersen L: Serum sex hormone concentrations in insulin-dependent diabetic women with and without amenorrhoea. Clin Endocrinol (Oxf) 1985;23:147–154.
Clarson C, Daneman D, Ehrlich RM: The relationship of metabolic control to growth and pubertal development in children with insulin-dependent diabetes. Diabetes Res 1985;2:237–241.
Thon A, Heinze E, Feilen KD, Holl RW, Schmidt H, Koletzko S, Wendel U, Nothjunge J: Development of height and weight in children with diabetes mellitus: Report on two prospective multicentre studies, one cross-sectional, one longitudinal. Eur J Pediatr 1992;151:258–262.
Gregory JW, Wilson AC, Greene SA: Body fat and overweight among children and adolescents with diabetes mellitus. Diabet Med 1992;9:344–348.
Holl RW, Grabert M, Sorgo W, Heinze E, Debatin KM: Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia 1998;41:542–547.
Danne T, Kordonouri O, Enders I, Weber B: Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997;20:281–285.
Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB: Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: Longitudinal study during adolescence. J Clin Endocrinol Metab 2001;86:1188–1193.
Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst, JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903–908.
Kamoda T, Saitoh H, Nakahara S, Izumi I, Hirano T, Matsui A: Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin Endocrinol (Oxf) 1998;49:385–389.
Kiess W, Anil M, Blum WF, Englaro P, Juul A, Attanasio A, Dotsch J, Rascher W: Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index. Eur J Endocrinol 1998;138:501–509.
Escobar-Morreale HF, Roldan B, Barrio R, Alonso M, Sancho J, de-la-Calle H, Garcia-Robles R: High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2000;85:4182–4187.
Adcock CJ, Perry LA, Lindsell DRM, Taylor AM, Holly JMP, Jones J, Dunger DB: Menstrual irregularities are more common in adolescents with type 1 diabetes: Association with poor glycaemic control and weight gain. Diabet Med 1994;11:465–470.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.